Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
314 studies found for:    pancreatitis
Show Display Options
Rank Status Study
1 Recruiting Laparoscopic Cholecystectomy in Idiopathic Pancreatitis
Condition: Idiopathic Pancreatitis
Intervention: Procedure: Laparoscopic cholecystectomy
2 Not yet recruiting Thiopurine Induced Pancreatitis in IBD Patients
Conditions: Pancreatitis;   Inflammatory Bowel Diseases
Intervention: Drug: Azathioprine
3 Completed Decrease of Recurrent Pancreatitis
Condition: Pancreatitis
Intervention: Behavioral: Repeated behavioural intervention without any drugs
4 Recruiting PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL
Conditions: Acute Lymphoblastic Leukemia;   Pancreatitis
Intervention:
5 Completed
Has Results
A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Condition: Pancreatitis
Interventions: Drug: aprepitant;   Drug: Placebo
6 Suspended Albumindialysis in Acute Pancreatitis
Conditions: Pancreatitis;   Multiple Organ Failure
Intervention: Device: Molecular adsorbent recirculating system
7 Not yet recruiting Bone Disease in Chronic Pancreatitis: A Complex Phenomenon
Conditions: Chronic Pancreatitis;   Osteopenia;   Osteoporosis
Intervention:
8 Recruiting Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Condition: Pancreatitis, Chronic
Intervention: Behavioral: Mobile Mindfulness Therapy
9 Recruiting Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
Condition: Post-ERCP Acute Pancreatitis
Interventions: Drug: Indomethacin;   Drug: Placebo
10 Recruiting Indomethacin Decreases Post-ERCP Pancreatitis
Condition: Post ERCP Acute Pancreatitis
Interventions: Drug: Indomethacin;   Drug: 2.6-g suppository of glycerin
11 Terminated Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients
Condition: Pancreatitis
Interventions: Drug: diclofenac;   Drug: placebo
12 Recruiting Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis
Conditions: Acute Pancreatitis;   Pancreatitis
Intervention: Other: No intervention
13 Terminated Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Other: chronic pancreatitis
14 Recruiting Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
Condition: Post-ERCP Pancreatitis
Interventions: Drug: high dose indomethacin;   Other: standard dose
15 Completed ERCP in Idiopathic Recurrent Acute Pancreatitis
Condition: Recurrent Acute Pancreatitis
Interventions: Procedure: Biliary sphincterotomy;   Procedure: Pancreatobiliary sphincterotomy;   Procedure: Sham
16 Recruiting Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
Condition: Post-ERCP Acute Pancreatitis
Interventions: Drug: Pre-operational rectal Indomethacin;   Drug: Post-operational Rectal Indomethacin
17 Active, not recruiting Evaluation of Prognosis and Prognostic Scores in Geriatric Patients With Acute Pancreatitis
Condition: Acute Pancreatitis
Intervention:
18 Recruiting Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis
Condition: Post-ERCP Acute Pancreatitis
Intervention: Drug: Hemin
19 Unknown  EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
Condition: Pancreatitis
Interventions: Drug: Magnesium  (15 mmol/d);   Drug: ANTOX (vers.) 1.2 (300 µg organic selenium, 54000 IU beta carotene, 750 mg vitamin C, 540 IU vitamin E, 2700 mg methionine)
20 Unknown  Efficacy of Administration of Somatostatin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Condition: Acute Pancreatitis
Interventions: Other: fisiologic serum;   Drug: somatostatin, intravenous bolus;   Drug: somatostatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years